ESC Premium Access

Comorbidities in Heart Failure: What Could Be Done Better?

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Comorbidities
Session type: Advances in Science
Date: 31 August 2020
Time: 08:30 - 08:30

Session

3 presentations in this session

Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease

Speaker: Mr E. Fu (Leiden, NL)
Thumbnail

Myocardial iron depletion exacerbates end-stage heart failure by promoting adverse remodeling and worsening mitochondrial function

Speaker: Doctor H. Zhang (Edmonton, CA)
Thumbnail

New-onset type 2 diabetes in heart failure: impact of heart failure and death versus ischemic events - a danish nationwide cohort study.

Speaker: Mrs B. Zareini (Copenhagen, DK)
Thumbnail

3 speakers from this session

Mr Edouard Fu

Leiden University Medical Center, Leiden (Netherlands (The))
0 follower

Doctor Hao Zhang

University of Alberta, Edmonton (Canada)
0 follower

Mrs Bochra Zareini

Gentofte University Hospital, Copenhagen (Denmark)
0 follower

This platform is supported by

logo Novo Nordisk